PMID: 8586259Dec 15, 1995Paper

Isolation and structure of a new integron that includes a streptomycin resistance gene from the R plasmid of Pseudomonas aeruginosa

FEMS Microbiology Letters
H KazamaT Arai

Abstract

A new integron, located on the R plasmid of Pseudomonas aeruginosa, was isolated in Japan. This integron was made up of two conserved segments (5'-and 3'-conserved segments) and a single streptomycin resistance gene as a gene cassette. The structure of this integron resembles that of integron InC, the existence of which was postulated by Bissonnette and Roy (J. Bacteriol. 174, 1248-1257, 1992).

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 1, 1991·FEMS Microbiology Letters·A S Purewal
Aug 1, 1985·Antimicrobial Agents and Chemotherapy·M TanakaT Yamamoto
Aug 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·S N CohenL Hsu
May 1, 1994·Antimicrobial Agents and Chemotherapy·A Bito, M Susani

❮ Previous
Next ❯

Citations

May 25, 2010·World Journal of Microbiology & Biotechnology·A K GoelS C Jiang
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·B GuerraM C Mendoza
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Keith Poole
May 23, 2006·Microbes and Infection·Michael R MulveyAxel Cloeckaert
Apr 23, 2015·Microbiology·Sara DominguesKaare Magne Nielsen
Oct 22, 2010·BMC Genomics·Julien Tremblay, Eric Déziel
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J RuizJ Vila
Jun 27, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·D Sandvang, F M Aarestrup
Oct 19, 2017·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Dinesh SubediMark Willcox
Mar 4, 2000·Journal of Food Protection·G RajashekaraK V Nagaraja
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·C E Briggs, P M Fratamico
Jun 1, 2001·Toxicon : Official Journal of the International Society on Toxinology·Y KomoriT Nikai
Oct 26, 2002·International Journal of Medical Microbiology : IJMM·Robyn M Doyle, Michael W Heuzenroeder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.